<DOC>
	<DOCNO>NCT00235482</DOCNO>
	<brief_summary>The purpose study determine safety injection coxsackievirus A21 melanoma tumour , also see tumour response .</brief_summary>
	<brief_title>Intratumoural Administration Coxsackievirus A21 Control Malignant Melanoma</brief_title>
	<detailed_description>Coxsackievirus A21 , naturally occur enterovirus , show vivo infect lyse melanoma . This study ass safety single intratumoural injection virus accessible subcutaneous melanoma metastasis .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Coxsackievirus Infections</mesh_term>
	<criteria>stage IV melanoma ( AJCC classification ) minimum 2 sc metastasis failure refusal standard chemotherapy ECOG score 0 1 metastatic CNS disease ocular mucosal melanoma immunodeficiency splenectomy</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2007</verification_date>
</DOC>